PharmacoEconomics

Acknowledgement

Continuous Time Simulation and Discretized Models for Cost-Effectiveness Analysis

Marta O. Soares, Luísa Canto e Castro

Bevacizumab for Metastatic Colorectal Cancer

Sophie Whyte, Abdullah Pandor, Matt Stevenson

A Systematic Review and Critical Assessment of Health State Utilities

Scott Doyle, Andrew Lloyd, Lee Moore, Joshua Ray, Alastair Gray

Cost Effectiveness of Therapeutic Interventions in Ankylosing Spondylitis

Cécile Gaujoux-Viala, Bruno Fautrel

Cost Effectiveness of Oromucosal Cannabis-Based Medicine (Sativex®) for Spasticity in Multiple Sclerosis

Lanting Lu, Hilary Pearce, Chris Roome, James Shearer, Iain A. Lang, Ken Stein

Chemotherapy Administration

Philip Haywood, Johan de Raad, Kees van Gool, Marion Haas, Gisselle Gallego, Sallie-Anne Pearson, Margaret Faedo, Robyn Ward

What’s Good and Bad About Contraceptive Products?

Stephanie A. Knox, Rosalie C. Viney, Deborah J. Street, Marion R. Haas, Denzil G. Fiebig, Edith Weisberg, Deborah Bateson

Impact of Transformation of Negative Values and Regression Models on Differences Between the UK and US EQ-5D Time Trade-Off Value Sets

Liv Ariane Augestad, Kim Rand-Hendriksen, Ivar Sønbø Kristiansen, Knut Stavem